Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Fisetin, found in fruits and vegetables, may help treat various health conditions like inflammation, diabetes, heart issues, cancer, and hair loss.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

5-α-reductase inhibitors, intralesional steroids, and hydroxychloroquine are the most effective treatments for frontal fibrosing alopecia.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.